Tumor microenvironment in chemoresistance, metastasis and immunotherapy of pancreatic cancer.

Pancreatic cancer chemoresistance immunotherapy metastasis tumor microenvironment

Journal

American journal of cancer research
ISSN: 2156-6976
Titre abrégé: Am J Cancer Res
Pays: United States
ID NLM: 101549944

Informations de publication

Date de publication:
2020
Historique:
received: 22 06 2020
accepted: 30 06 2020
entrez: 11 8 2020
pubmed: 11 8 2020
medline: 11 8 2020
Statut: epublish

Résumé

Pancreatic cancer (PC) is a fatal disease with high malignancy and difficult for early diagnosis. PC causes more than 400,000 patient deaths world widely and becomes the severe health problems. The tumor microenvironment (TME) is comprised of acellular stroma, pancreatic stellate cells, immune cells, and soluble factors. TME is maintained by continuous cell-matrix and cell-cell interactions. TME induced by the interaction among pancreatic cancer cells, epithelial cells and stromal cells is essential for the progression of PC and leads to resistance to chemotherapy. Components in the microenvironment can also promote the formation of connective tissue in the primary or metastatic site, or promote the metastatic ability of PC by enhancing angiogenesis, epithelial-mesenchymal transformation, and lymph angiogenesis. In addition, the TME also leaves pancreatic cancer unsusceptible to different immunotherapeutic strategies. In this review, we summarized the current knowledge about TME in PC. And the focus was placed on the role of TME in chemotherapeutic resistance and metastasis in the field of PC. And we also paid attention to the immunological therapy targeting the TME, aiming to provide the novel therapy for pancreatic cancer.

Identifiants

pubmed: 32774994
pmc: PMC7407356

Types de publication

Journal Article Review

Langues

eng

Pagination

1937-1953

Informations de copyright

AJCR Copyright © 2020.

Déclaration de conflit d'intérêts

None.

Références

Br J Cancer. 2014 Jan 7;110(1):172-82
pubmed: 24178759
Ann N Y Acad Sci. 2005 Nov;1059:184-95
pubmed: 16382054
Int J Mol Sci. 2016 Jun 03;17(6):
pubmed: 27271610
J Pharmacol Exp Ther. 2004 Aug;310(2):520-7
pubmed: 15056726
Hum Vaccin Immunother. 2014;10(11):3354-68
pubmed: 25483688
Nat Rev Cancer. 2008 Mar;8(3):180-92
pubmed: 18273037
J Hematol Oncol. 2018 Aug 13;11(1):102
pubmed: 30103775
Cancer Lett. 2017 Jul 1;397:43-51
pubmed: 28336327
Cancer Sci. 2018 Jan;109(1):132-140
pubmed: 29121426
Science. 2010 May 7;328(5979):749-52
pubmed: 20339029
Cancer Res. 2006 Jan 15;66(2):1123-31
pubmed: 16424049
Oncogene. 2017 Mar 30;36(13):1770-1778
pubmed: 27669441
Cancer Cell. 2014 Jun 16;25(6):719-34
pubmed: 24856586
Oncologist. 2018 Oct;23(10):1260
pubmed: 30315083
Oncogene. 2013 Sep 26;32(39):4614-21
pubmed: 23108411
Angiogenesis. 2016 Jul;19(3):359-71
pubmed: 27106789
J Surg Oncol. 2010 Dec 1;102(7):809-15
pubmed: 20886557
Nat Genet. 2017 Mar;49(3):367-376
pubmed: 28092686
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20212-7
pubmed: 24277834
Front Physiol. 2012 Jul 13;3:270
pubmed: 22969725
Gut. 2018 Feb;67(2):320-332
pubmed: 27797936
Gut. 2006 Jan;55(1):79-89
pubmed: 16043492
Cancer Cell. 2014 Jun 16;25(6):735-47
pubmed: 24856585
J Exp Clin Cancer Res. 2019 Apr 15;38(1):162
pubmed: 30987642
Cancer Res. 2008 Feb 1;68(3):918-26
pubmed: 18245495
Lung Cancer. 2019 Sep;135:188-195
pubmed: 31446994
Pancreatology. 2019 Mar;19(2):383-389
pubmed: 30670333
J Exp Med. 2017 Mar 6;214(3):579-596
pubmed: 28232471
Pancreas. 2004 Nov;29(4):254-63
pubmed: 15502640
Oncol Rep. 2015 Apr;33(4):1883-9
pubmed: 25672829
Cancer Ther. 2008;6(B):955-964
pubmed: 19129927
Front Oncol. 2014 May 09;4:102
pubmed: 24847445
Sci Signal. 2012 Jun 26;5(230):ra46
pubmed: 22740686
Cancer Res. 2018 Sep 15;78(18):5287-5299
pubmed: 30042153
Oncoimmunology. 2013 Dec 1;2(12):e27231
pubmed: 24498570
Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E4041-E4050
pubmed: 29632196
Mol Cancer. 2016 Jan 06;15:3
pubmed: 26739387
Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):331-341
pubmed: 30826427
Gut. 2002 Oct;51(4):579-84
pubmed: 12235084
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Gastroenterology. 2018 Sep;155(3):880-891.e8
pubmed: 29909021
Clin Cancer Res. 2004 Nov 15;10(22):7775-84
pubmed: 15570012
Tumour Biol. 2016 Nov;37(11):15283-15291
pubmed: 27696296
World J Gastroenterol. 2014 Aug 28;20(32):11160-81
pubmed: 25170202
JCI Insight. 2018 Apr 5;3(7):
pubmed: 29618658
Mol Cancer. 2019 Mar 30;18(1):48
pubmed: 30925924
Nature. 2015 Nov 19;527(7578):329-35
pubmed: 26524530
Nat Commun. 2019 Aug 28;10(1):3874
pubmed: 31462678
Science. 2017 Mar 31;355(6332):1428-1433
pubmed: 28280247
Oncogene. 2009 Oct 8;28(40):3513-25
pubmed: 19633682
Int J Cancer. 2013 Feb 15;132(4):785-94
pubmed: 22821831
Oncotarget. 2015 Feb 20;6(5):3085-97
pubmed: 25609203
Cancer Immunol Immunother. 2015 Feb;64(2):149-59
pubmed: 25305035
Nature. 2005 Dec 8;438(7069):820-7
pubmed: 16341007
Cancer Immunol Immunother. 2014 May;63(5):513-28
pubmed: 24652403
Cancer Res. 2016 Dec 1;76(23):6851-6863
pubmed: 27742686
Cancer Res. 2011 Apr 1;71(7):2550-60
pubmed: 21300765
Mol Cancer. 2018 Jul 30;17(1):108
pubmed: 30060755
Hum Gene Ther. 2014 Dec;25(12):1003-12
pubmed: 24694017
Clin Cancer Res. 2016 Jan 15;22(2):415-25
pubmed: 26405195
Cancer J. 2017 Nov/Dec;23(6):321-325
pubmed: 29189327
Cancer Cell. 2012 Mar 20;21(3):418-29
pubmed: 22439937
Nat Rev Clin Oncol. 2020 May 12;:
pubmed: 32398706
Immunity. 2016 Jun 21;44(6):1444-54
pubmed: 27332733
Clin Immunol Immunopathol. 1993 Feb;66(2):91-106
pubmed: 8453790
PLoS One. 2014 Sep 05;9(9):e106741
pubmed: 25191901
Oncotarget. 2017 Apr 11;8(15):24840-24852
pubmed: 28193910
Br J Cancer. 2012 Jan 17;106(2):348-57
pubmed: 22146521
Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):E4410-7
pubmed: 26216984
Sci Rep. 2019 Jul 31;9(1):11131
pubmed: 31366979
Cancer Res. 2011 May 15;71(10):3453-8
pubmed: 21558392
Cancer Cell. 2015 Dec 14;28(6):831-833
pubmed: 28843279
PLoS One. 2012;7(11):e47519
pubmed: 23139748
Cancer Lett. 2017 Jan 28;385:65-74
pubmed: 27840243
Mol Med Rep. 2012 Apr;5(4):959-63
pubmed: 22246595
Cytokine. 2017 Jan;89:194-200
pubmed: 26868086
Cancer Cell. 2012 Jun 12;21(6):836-47
pubmed: 22698407
Cancer Cell. 2015 Nov 9;28(5):638-652
pubmed: 26525103
J Immunol. 2004 Jul 15;173(2):945-54
pubmed: 15240681
Gut. 2002 Apr;50(4):535-41
pubmed: 11889076
Medicine (Baltimore). 2016 Dec;95(49):e5541
pubmed: 27930550
Cancer Res. 2008 Oct 1;68(19):7707-10
pubmed: 18829522
Lab Invest. 2013 Jul;93(7):844-54
pubmed: 23752129
Arch Pathol Lab Med. 2009 Mar;133(3):413-22
pubmed: 19260747
Oncogene. 2014 Jul 17;33(29):3812-9
pubmed: 23995783
Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):E1275-84
pubmed: 22084065
Med Sci Monit. 2019 Aug 30;25:6518-6522
pubmed: 31469816
Cancer Discov. 2016 Feb;6(2):166-75
pubmed: 26658419
Int J Biochem Cell Biol. 2016 Jun;75:131-9
pubmed: 27017975
Cell. 2012 Jan 20;148(1-2):349-61
pubmed: 22265420
Sci Rep. 2016 Oct 20;6:35848
pubmed: 27762323
Radiother Oncol. 2014 May;111(2):243-51
pubmed: 24780634
Exp Cell Res. 2008 Jun 10;314(9):1923-8
pubmed: 18410925
Cell Mol Life Sci. 2016 Apr;73(7):1333-48
pubmed: 26626411
Minerva Gastroenterol Dietol. 2017 Mar;63(1):50-54
pubmed: 27824244
Sci Rep. 2019 Aug 7;9(1):11472
pubmed: 31391510
Clin Cancer Res. 2004 Dec 15;10(24):8413-20
pubmed: 15623620
Gastroenterology. 2013 Jun;144(6):1210-9
pubmed: 23622130
Eur J Cancer. 2014 Oct;50(15):2570-82
pubmed: 25091797
Oncol Rep. 2017 Apr;37(4):1971-1979
pubmed: 28260082
Immunity. 2014 Jul 17;41(1):49-61
pubmed: 25035953
Gastroenterology. 2013 Jun;144(6):1241-8
pubmed: 23622133
J Clin Invest. 2014 Jun;124(6):2425-40
pubmed: 24812664
Oncogene. 2003 Jan 23;22(3):319-29
pubmed: 12545153
World J Gastroenterol. 2005 Jun 14;11(22):3385-91
pubmed: 15948243
Gut. 2013 Jan;62(1):112-20
pubmed: 22466618
Pancreas. 2013 Jan;42(1):155-9
pubmed: 22699204
J Immunol. 2009 Aug 1;183(3):1767-79
pubmed: 19587009
Curr Opin Gastroenterol. 2013 Sep;29(5):537-43
pubmed: 23892539
Science. 2008 Sep 26;321(5897):1801-6
pubmed: 18772397
Semin Oncol. 2014 Apr;41(2):235-51
pubmed: 24787295
EMBO Mol Med. 2015 Jun 15;7(8):1063-76
pubmed: 26077591
Cancer Res. 2000 Dec 15;60(24):7075-83
pubmed: 11156414
Int J Oncol. 2015 Mar;46(3):933-43
pubmed: 25573346
Cancer Lett. 2017 Apr 28;392:83-93
pubmed: 28189533
Gut. 1998 Jul;43(1):128-33
pubmed: 9771417
Gut. 2019 Jun;68(6):1052-1064
pubmed: 30121627
Pancreatology. 2015 Jul;15(4 Suppl):S32-8
pubmed: 25845856
Am J Pathol. 1999 Oct;155(4):1087-95
pubmed: 10514391
Nat Cell Biol. 2015 Jun;17(6):816-26
pubmed: 25985394

Auteurs

Shunda Wang (S)

Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College Beijing 100730, China.

Yatong Li (Y)

Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College Beijing 100730, China.

Cheng Xing (C)

Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College Beijing 100730, China.

Cheng Ding (C)

Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College Beijing 100730, China.

Hanyu Zhang (H)

Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College Beijing 100730, China.

Lixin Chen (L)

Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College Beijing 100730, China.

Lei You (L)

Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College Beijing 100730, China.

Menghua Dai (M)

Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College Beijing 100730, China.

Yupei Zhao (Y)

Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College Beijing 100730, China.

Classifications MeSH